Sinsin Pharmaceutical Co. Ltd (002800) - Total Liabilities

Latest as of September 2025: ₩65.10 Billion KRW ≈ $44.12 Million USD

Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has total liabilities worth ₩65.10 Billion KRW (≈ $44.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Sinsin Pharmaceutical Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.

Sinsin Pharmaceutical Co. Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Sinsin Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002800 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Sinsin Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
3I Infrastructure PLC LSE:3IN	UK	GBX387.00 Million
IBKS No2 SPAC KQ:204840	Korea	₩28.80 Billion
Prodways Group SA PA:PWG	France	€44.96 Million
Bragg Gaming Group Inc TO:BRAG	Canada	CA$59.00 Million
Jerash Holdings US Inc NASDAQ:JRSH	USA	$20.56 Million
Scan-D TWO:6195	Taiwan	NT$2.33 Billion
Phunware Inc NASDAQ:PHUN	USA	$6.49 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Sinsin Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Sinsin Pharmaceutical Co. Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.91	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinsin Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual total liabilities of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩63.61 Billion ≈ $43.11 Million	+2.07%
2023-12-31	₩62.32 Billion ≈ $42.23 Million	+1.31%
2022-12-31	₩61.52 Billion ≈ $41.69 Million	+3.59%
2021-12-31	₩59.38 Billion ≈ $40.24 Million	-4.13%
2020-12-31	₩61.94 Billion ≈ $41.98 Million	-15.01%
2019-12-31	₩72.87 Billion ≈ $49.39 Million	+36.52%
2018-12-31	₩53.38 Billion ≈ $36.18 Million	+99.66%
2017-12-31	₩26.74 Billion ≈ $18.12 Million	-22.23%
2016-12-31	₩34.38 Billion ≈ $23.30 Million	--

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.56 Million

₩62.81 Billion KRW

Market Cap Rank

#22443 Global

#1397 in Korea

Share Price

₩4140.00

Change (1 day)

+2.99%

52-Week Range

₩4015.00 - ₩6630.00

All Time High

₩13396.03